| scholarly article | Q13442814 |
| P50 | author | Shayan Waseh | Q57476631 |
| Michael D. Garrick | Q47796123 | ||
| P2093 | author name string | Lin Zhao | |
| Joseph F Quinn | |||
| Zihua Hu | |||
| Daniel Sternberg | |||
| Zohara Sternberg | |||
| Kaye Jeffrey | |||
| Katharine Wild | |||
| P2860 | cites work | sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin | Q24298395 |
| Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization | Q24310115 | ||
| Hepcidin--the iron regulatory hormone | Q24536439 | ||
| Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease | Q24651822 | ||
| Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter | Q28145559 | ||
| Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation | Q28186993 | ||
| Assignment of human ferritin genes to chromosomes 11 and 19q13.3----19qter | Q28305793 | ||
| The ferritins: molecular properties, iron storage function and cellular regulation | Q28609366 | ||
| Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. | Q30362213 | ||
| Core candidate neurochemical and imaging biomarkers of Alzheimer's disease | Q31162752 | ||
| Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment | Q33740552 | ||
| Clinical practice. Mild cognitive impairment | Q33925962 | ||
| Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress | Q33964988 | ||
| Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. | Q34181256 | ||
| Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview | Q34277859 | ||
| The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. | Q52582786 | ||
| Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells | Q56974269 | ||
| Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report | Q57317953 | ||
| Ferritin Heavy Chain Upregulation by NF-κB Inhibits TNFα-Induced Apoptosis by Suppressing Reactive Oxygen Species | Q58419541 | ||
| The iron content of serum ferritin: physiological importance and diagnostic value | Q73349406 | ||
| Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation | Q73577498 | ||
| Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk | Q79279445 | ||
| Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations | Q84595476 | ||
| Body iron stores in relation to risk of type 2 diabetes in apparently healthy women | Q34297017 | ||
| A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains | Q34300345 | ||
| Anemia of chronic disease. | Q34401570 | ||
| Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease | Q34802970 | ||
| Intrathecal inflammation precedes development of Alzheimer's disease | Q35476365 | ||
| Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI | Q35821382 | ||
| Biomarkers of Alzheimer disease in plasma | Q36045288 | ||
| The role of iron in diabetes and its complications | Q36788911 | ||
| Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain | Q36796653 | ||
| Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease | Q37181302 | ||
| Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database | Q37300216 | ||
| Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future | Q37422795 | ||
| Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease. | Q37691070 | ||
| Metals, oxidative stress and neurodegenerative disorders | Q37781744 | ||
| Human iron transporters | Q37857677 | ||
| Metal dyshomeostasis and oxidative stress in Alzheimer's disease | Q38043839 | ||
| The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders | Q38198015 | ||
| Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha | Q38294141 | ||
| Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
| Multifunctional iron-chelators with protective roles against neurodegenerative diseases. | Q39181472 | ||
| Structural and immunological relationships of isoferritins in normal and malignant cells | Q39379847 | ||
| How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond? | Q40263591 | ||
| The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease | Q41661825 | ||
| Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis. | Q42461077 | ||
| Importance of hypoglycemia on the risk of Alzheimer's disease in elderly subjects with diabetes mellitus | Q43182104 | ||
| An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript | Q44116151 | ||
| Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. | Q46628661 | ||
| Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. | Q46645329 | ||
| Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation | Q46686159 | ||
| A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. | Q46827803 | ||
| Macrophages function as a ferritin iron source for cultured human erythroid precursors | Q46976742 | ||
| Relationship between brain R(2) and liver and serum iron concentrations in elderly men. | Q48334368 | ||
| Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. | Q48552163 | ||
| Transferrin receptor on endothelium of brain capillaries | Q48602638 | ||
| Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. | Q48861931 | ||
| Ferritin H is a novel marker of early erythroid precursors and macrophages. | Q50492019 | ||
| Hypoglycemia in Alzheimer's disease. | Q51660919 | ||
| Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. | Q51762261 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 215-227 | |
| P577 | publication date | 2017-04-01 | |
| P1433 | published in | Aging and Disease | Q20312700 |
| P1476 | title | Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease | |
| P478 | volume | 8 |
| Q64981447 | DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration. |
| Q49885816 | Hepcidin, an emerging and important player in brain iron homeostasis. |
| Q58754278 | Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications |
| Q53698735 | No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. |
| Q92801350 | Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and Assessment |
| Q60046944 | Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease |
| Q60949622 | Vitamin B12 Levels in Methamphetamine Addicts |
Search more.